6th Annual World Life Sciences Conference
1 Jun - 2 Jun 2018
Session information
Roundtables - Topic ten Reverse mergers of Life Sciences companies
Friday 1 June (0930 - 1230)
Committee(s)
Intellectual Property and Entertainment Law Committee
(Lead)
Life Sciences Subcommittee
(Lead)
Description
The IPO market for Life Sciences companies in recent years has been slow. In order to facilitate financing such companies, many have opted to reverse merge into publicly traded shells. Such transactions enable early stage companies which would have otherwise not been able to file a prospectus, to become publicly traded entities and attract the public and other, nonventure capital related, investors. The round table will enable the participants to discuss the key issues and lessons learned in structuring, evaluating and negotiating reverse mergers, and the reality of becoming a publicly traded company at an early stage.
Session / Workshop Chair(s)
| Marc Mantell | Mintz Levin, Boston, Massachusetts, USA |
| Rick Pierce | FEP Capital Advisors, Cambridge, Massachusetts, USA |